Observed Signal · Aug 20, 2026 · Market Signal · Source: Medtronic · Impact: 5/5

Medtronic announces cash dividend for second quarter of fiscal year 2027

Executive Signal Summary

The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 20, 2026, approved the company's cash dividend for the second quarter of fiscal year 2027 of $0.72 per ordinary share. This...

SIGNAL RADAR

Track Medtronic Signals & Market Shifts in Real-Time

Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.

Start Monitoring
Verified primary sourcesAutomated briefingsInstant watchlist setup
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: Medtronic•Published: Aug 20, 2026

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

Market IntelligenceOct 7, 2026

Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.

Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of common stock of MiniMed Group, Inc.

Read assessment
financialsSep 3, 2026

10-Q Financial Filing Analysis for Medtronic (2026-09-03)

Medtronic plc reported net sales of $9.756 billion for Q1 FY2027 (ended July 31, 2026), marking a 14% year-over-year increase supported by broad segment growth and an additional fiscal week. The company actively expanded its neuroscience portfolio through strategic acquisitions of Scientia Vascular ($681 million) and SPR Therapeutics ($654 million). Additionally, Medtronic advanced the full divestiture of its remaining stake in MiniMed Group following its March 2026 IPO, and executed post-quarter strategic transactions including a $700 million investment in Cornerstone Robotics and a $1.0 billion cross-currency swap. However, the company faces material legal headwinds, actively contesting a $382 million antitrust verdict (subject to trebling) and an $88 million product liability award.

Read assessment
Market IntelligenceSep 14, 2026

Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.

Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMed. Provides Medtronic shareholders with option for a generally tax-free exchange for U.S. federal income tax...

Read assessment
Executive Briefing & Watchlist

Receive all future signals for Medtronic & competitors in your briefing

Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.

Daily primary source scansCurated executive briefingsUnsubscribe anytime